Company
Invivyd
Invivyd is improving lives with medicines for serious infectious diseases.
- Business model
- B2B
- Legal name
- Invivyd, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Invivyd is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases.
Funding snapshot
- Total raised
- $489MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $23.7M2022-11-15
Funding rounds
- Round, 2022
- $23.7M2022-11-15, SEC form D sold, 1 investor
- Round, 2021
- $335M2021-04-16, SEC form D sold, 36 investors
- Round, 2020
- $80M2020-10-30, SEC form D sold, 16 investors
- Round, 2020
- $49.9M2020-07-09, SEC form D sold, 24 investors
Loading relationship preview